Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1982-06-11
1985-02-19
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514398, 514399, 514256, 514381, 514886, 514910, A61K 31415, A61K 31305, A61K 3144, A61K 3140
Patent
active
045005400
ABSTRACT:
The present disclosure relates to the use of thromboxane synthase inhibitors as antiobesity agents and insulin lowering agents. Such compounds fall into a variety of classes among which are 1-substituted imidazoles, 4-substituted imidazoles, 3-substituted pyridines, 3-substituted indoles, 4-substituted pyrimidines, 5-substituted tetrazoles, pyrazolidines, quinazolines, and substituted xanthene carboxylic acids.
REFERENCES:
patent: 3637731 (1972-01-01), Johnson
patent: 3821415 (1974-06-01), Heyes et al.
patent: 3867539 (1975-02-01), Henkin
patent: 3880871 (1975-04-01), Haugwitz et al.
patent: 3991201 (1976-11-01), Heeres et al.
patent: 3996366 (1976-12-01), Baker et al.
Chem. Abst. 82, 118,787(h) (1975) Aeberli et al.
Chem. Abst. 74, 96456(e) (1971)-Lefebvre et al.
Chem. Abst. 76, 108,708(v) (1972)-Malaisse.
Merck 9th ed. item 4845-1976 Merck & Co.
Hamilton James G.
Sullivan Ann C.
Tobias Lawrence D.
Triscari Joseph
Boxer Matthew
Hoffmann-La Roche Inc.
Leon Bernard S.
Robinson Douglas W.
Saxe Jon S.
LandOfFree
Thromboxane synthase inhibitors as insulin lowering agents and a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thromboxane synthase inhibitors as insulin lowering agents and a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thromboxane synthase inhibitors as insulin lowering agents and a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-612975